Table 2

Effect of baseline CD4+ T cell counts on any treatment-emergent adverse effects

VariableUnadjustedP valueAdjusted*P value
OR (95% CI)OR (95% CI)
HIV statusPeople living with HIVRef
HIV-negative0.41 (0.14 to 1.16)0.090.51 (0.03 to 8.88)0.6
CD4+ T cell count≥350RefRef
<3505.19 (1.35 to 19.96)0.027.74 (0.75 to 79.56)0.09
SexCisgender maleRefRef
Cisgender female1.33 (0.46 to 3.82)0.66.21 (0.87 to 44.64)0.07
EthnicityHispanic or LatinoRefRef
Not Hispanic or Latino0.93 (0.24 to 3.61)0.90.88 (0.15 to 5.33)0.9
Not reported0.09 (0.01 to 1.31)0.080.09 (0.003 to 2.16)0.14
Age(per year)1.03 (0.99 to 1.08)0.161.05 (0.98 to 1.12)0.16
Prior systemic therapies(per number of therapies)0.9 (0.70 to 1.11)0.30.84 (0.63 to 1.13)0.3
Prior radiotherapyNoRefRef
Yes0.6 (0.22 to 1.59)0.38 (0.03 to 4.45)0.4
  • *Adjusted for sex, ethnicity, age, CD4+ T cell count, number of prior systemic therapies, prior radiotherapy, and HIV status.